BofA Securities analyst Lyanne Harrison reiterated a Buy rating and $21.00 price target on Avita Medical Ltd. (NASDAQ: RCEL).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to NeutralMay 14, 2024 3:04 AM Form 10-Q AVITA Medical, Inc. For: Mar 31May 13, 2024 4:05 PM AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41cMay 13, 2024 4:04 PM Form 8-K AVITA Medical, Inc. For: May 13May 13, 2024 4:03 PM AVITA Medical Reports First Quarter Financial ResultsMay 13, 2024 4:01 PM